Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice

Microbial Pathogenesis

Volumn 44, Issue 1, 2008, Pages 20-27

  Taylor, Jennifer M ^a   Ziman, Melanie E ^a   Canfield, Don R ^a,b   Vajdy, Michael ^a   Solnick, Jay V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adjuvant; Gastric immunity; H. pylori; Th1; Th2; Vaccine

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLERA TOXIN; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HELICOBACTER PYLORI VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HELPER CELL; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STOMACH; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CHOLERA TOXIN; COLONY COUNT, MICROBIAL; CYTOKINES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNIZATION; LIPOPOLYSACCHARIDES; MICE; SPECIFIC PATHOGEN-FREE ORGANISMS; STOMACH; TH1 CELLS; TH2 CELLS;

HELICOBACTER PYLORI; MUS;

EID: 36849094551     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2007.06.006     Document Type: Article

References (46)

1. Kusters J.G., van Vliet A.H., and Kuipers E.J. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19 3 (2006) 449-490
2. Suerbaum S., and Michetti P. Helicobacter pylori infection. N Engl J Med 347 15 (2002) 1175-1186
3. Del Giudice G., Covacci A., Telford J.L., Montecucco C., and Rappuoli R. The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol 19 (2001) 523-563
4. Blaser M.J., Chyou P.H., and Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 55 3 (1995) 562-565
5. Mitchell H.M., Li Y.Y., Hu P.J., Liu Q., Chen M., Du G.G., et al. Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period for acquisition. J Infect Dis 166 1 (1992) 149-153
6. Goto T., Nishizono A., Fujioka T., Ikewaki J., Mifune K., and Nasu M. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice. Infect Immun 67 5 (1999) 2531-2539
7. Marchetti M., Rossi M., Giannelli V., Giuliani M.M., Pizza M., Censini S., et al. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine 16 1 (1998) 33-37
8. Ikewaki J., Nishizono A., Goto T., Fujioka T., and Mifune K. Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection. Microbiol Immunol 44 1 (2000) 29-39
9. Del Giudice G., and Michetti P. Inflammation, immunity and vaccines for Helicobacter pylori. Helicobacter 9 Suppl 1 (2004) 23-28
10. Lundgren A., Trollmo C., Edebo A., Svennerholm A.M., and Lundin B.S. Helicobacter pylori-specific CD4(+) T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa. Infect Immun 73 9 (2005) 5612-5619
11. Louis E., Franchimont D., Piron A., Gevaert Y., Schaaf-Lafontaine N., Roland S., et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113 3 (1998) 401-406
12. Yamamoto T., Kita M., Ohno T., Iwakura Y., Sekikawa K., and Imanishi J. Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori infection. Microbiol Immunol 48 9 (2004) 647-654
13. Kamradt A.E., Greiner M., Ghiara P., and Kaufmann S.H. Helicobacter pylori infection in wild-type and cytokine-deficient C57BL/6 and BALB/c mouse mutants. Microbes Infect 2 6 (2000) 593-597
14. Shi T., Liu W.Z., Gao F., Shi G.Y., and Xiao S.D. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection. Helicobacter 10 1 (2005) 71-79
15. Sawai N., Kita M., Kodama T., Tanahashi T., Yamaoka Y., Tagawa Y., et al. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun 67 1 (1999) 279-285
16. Garhart C.A., Nedrud J.G., Heinzel F.P., Sigmund N.E., and Czinn S.J. Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. Infect Immun 71 6 (2003) 3628-3633
17. Akhiani A.A., Pappo J., Kabok Z., Schon K., Gao W., Franzen L.E., et al. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J Immunol 169 12 (2002) 6977-6984
18. Taylor J.M., Ziman M.E., Huff J.L., Moroski N.M., Vajdy M., and Solnick J.V. Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice. Vaccine 24 23 (2006) 4987-4994
19. Kotloff K.L., Sztein M.B., Wasserman S.S., Losonsky G.A., DiLorenzo S.C., and Walker R.I. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect Immun 69 6 (2001) 3581-3590
20. Maeda K., Yamashiro T., Minoura T., Fujioka T., Nasu M., and Nishizono A. Evaluation of therapeutic efficacy of adjuvant Helicobacter pylori whole cell sonicate in mice with chronic H. pylori infection. Microbiol Immunol 46 9 (2002) 613-620
21. Jeremy A.H., Du Y., Dixon M.F., Robinson P.A., and Crabtree J.E. Protection against Helicobacter pylori infection in the mongolian gerbil after prophylactic vaccination. Microbes Infect 8 2 (2006) 340-346
22. Roman M., Martin-Orozco E., Goodman J.S., Nguyen M.D., Sato Y., Ronaghy A., et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 3 8 (1997) 849-854
23. McCluskie M.J., and Davis H.L. Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants. Vaccine 19 4-5 (2000) 413-422
24. Xu-Amano J., Kiyono H., Jackson R.J., Staats H.F., Fujihashi K., Burrows P.D., et al. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 178 4 (1993) 1309-1320
25. Marinaro M., Staats H.F., Hiroi T., Jackson R.J., Coste M., Boyaka P.N., et al. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol 155 10 (1995) 4621-4629
26. Stevens T.L., Bossie A., Sanders V.M., Fernandez-Botran R., Coffman R.L., Mosmann T.R., et al. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334 6179 (1988) 255-258
27. Taylor J.M., Ziman M.E., Huff J.L., Moroski N.M., Vajdy M., and Solnick J.V. Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice. Vaccine (2006)
28. Lee A., and Chen M. Successful immunization against gastric infection with Helicobacter species: use of a cholera toxin B-subunit-whole-cell vaccine. Infect Immun 62 8 (1994) 3594-3597
29. Cao W., Chen Y., Alkan S., Subramaniam A., Long F., Liu H., et al. Human T helper (Th) cell lineage commitment is not directly linked to the secretion of IFN-gamma or IL-4: characterization of Th cells isolated by FACS based on IFN-gamma and IL-4 secretion. Eur J Immunol 35 9 (2005) 2709-2717
30. Gor D.O., Rose N.R., and Greenspan N.S. TH1TH2: a procrustean paradigm. Nat Immunol 4 6 (2003) 503-505
31. Keenan J.I., Rijpkema S.G., Durrani Z., and Roake J.A. Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens. FEMS Immunol Med Microbiol 36 3 (2003) 199-205
32. Garhart C.A., Heinzel F.P., Czinn S.J., and Nedrud J.G. Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent. Infect Immun 71 2 (2003) 910-921
33. Amieva M.R., Salama N.R., Tompkins L.S., and Falkow S. Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells. Cell Microbiol 4 10 (2002) 677-690
34. Aspholm M., Olfat F.O., Norden J., Sonden B., Lundberg C., Sjostrom R., et al. SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog 2 10 (2006) e110
35. Necchi V., Candusso M.E., Tava F., Luinetti O., Ventura U., Fiocca R., et al. Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori. Gastroenterology 132 3 (2007) 1009-1023
36. Dubois A., and Boren T. Helicobacter pylori is invasive and it may be a facultative intracellular organism. Cell Microbiol 9 5 (2007) 1108-1116
37. Piotrowski J., Piotrowski E., Skrodzka D., Slomiany A., and Slomiany B.L. Induction of acute gastritis and epithelial apoptosis by Helicobacter pylori lipopolysaccharide. Scand J Gastroenterol 32 3 (1997) 203-211
38. Sakagami T., Vella J., Dixon M.F., O'Rourke J., Radcliff F., Sutton P., et al. The endotoxin of Helicobacter pylori is a modulator of host-dependent gastritis. Infect Immun 65 8 (1997) 3310-3316
39. D'Elios M.M., Appelmelk B.J., Amedei A., Bergman M.P., and Del Prete G. Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol Med 10 7 (2004) 316-323
40. Mohammadi M., Czinn S., Redline R., and Nedrud J. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol 156 12 (1996) 4729-4738
41. Kursar M., Bonhagen K., Fensterle J., Kohler A., Hurwitz R., Kamradt T., et al. Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses. J Exp Med 196 12 (2002) 1585-1592
42. Raghavan S., Fredriksson M., Svennerholm A.M., Holmgren J., and Suri-Payer E. Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin Exp Immunol 132 3 (2003) 393-400
43. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., and Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197 4 (2003) 403-411
44. Satin B., Del Giudice G., Della Bianca V., Dusi S., Laudanna C., Tonello F., et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med 191 9 (2000) 1467-1476
45. Guadalupe M., Reay E., Sankaran S., Prindiville T., Flamm J., McNeil A., et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77 21 (2003) 11708-11717
46. Vajdy M., Singh M., Ugozzoli M., Briones M., Soenawan E., Cuadra L., et al. Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations. Immunology 110 1 (2003) 86-94